155 related articles for article (PubMed ID: 37710244)
21. [Performance of human papillomavirus typing test in cervical precancer lesions and cervical cancer screening].
Zhang SK; Luo XP; Li ZF; Su Z; Xia JC; Hu GY; Zhu YJ; Xie LX; Feng XX; Sun XB; Chen W; Qiao YL
Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):252-256. PubMed ID: 32252206
[No Abstract] [Full Text] [Related]
22. Human papillomavirus oncogene mRNA testing for the detection of anal dysplasia in HIV-positive men who have sex with men.
Silling S; Kreuter A; Hellmich M; Swoboda J; Pfister H; Wieland U
J Clin Virol; 2012 Apr; 53(4):325-31. PubMed ID: 22261122
[TBL] [Abstract][Full Text] [Related]
23. Performance of p16/Ki67 immunostaining, HPV E6/E7 mRNA testing, and HPV DNA assay to detect high-grade cervical dysplasia in women with ASCUS.
Zhu Y; Ren C; Yang L; Zhang X; Liu L; Wang Z
BMC Cancer; 2019 Mar; 19(1):271. PubMed ID: 30917784
[TBL] [Abstract][Full Text] [Related]
24. Risks for cervical abnormalities in women with non-16/18 high-risk human papillomavirus infections in south Shanghai, China.
Wang X; Wu S; Li Y
J Med Virol; 2021 Nov; 93(11):6355-6361. PubMed ID: 34232523
[TBL] [Abstract][Full Text] [Related]
25. Association between human papillomavirus type 16 E6 and E7 variants with subsequent persistent infection and recurrence of cervical high-grade squamous intraepithelial lesion after conization.
Zhang L; Yang B; Zhang A; Zhou A; Yuan J; Wang Y; Sun L; Cao H; Wang J; Zheng W
J Med Virol; 2016 Nov; 88(11):1982-8. PubMed ID: 27038009
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic Utility of HPV16 E6 mRNA or E7 mRNA Quantitative Expression for Cervical Cells of Patients with Dysplasia and Carcinoma.
Wu MZ; Li WN; Cha N; Tian LX; Zhang YI; Wu X; Guo KJ; Wu GP
Cell Transplant; 2018 Sep; 27(9):1401-1406. PubMed ID: 30056761
[TBL] [Abstract][Full Text] [Related]
27. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.
Arbyn M; Roelens J; Simoens C; Buntinx F; Paraskevaidis E; Martin-Hirsch PP; Prendiville WJ
Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008054. PubMed ID: 23543559
[TBL] [Abstract][Full Text] [Related]
28. Triage of HR-HPV positive women with minor cytological abnormalities: a comparison of mRNA testing, HPV DNA testing, and repeat cytology using a 4-year follow-up of a population-based study.
Persson M; Elfström KM; Brismar Wendel S; Weiderpass E; Andersson S
PLoS One; 2014; 9(2):e90023. PubMed ID: 24587193
[TBL] [Abstract][Full Text] [Related]
29. [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].
Luo HX; Du H; Liu ZH; Zhang LJ; Wang C; Wu RF
Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):232-238. PubMed ID: 29575846
[No Abstract] [Full Text] [Related]
30. [Comparative study of HR HPV E6/E7 mRNA and HR-HPV DNA in cervical cancer screening].
Zhao X; Cui Y; Jiang S; Meng Y; Liu A; Wei L; Liu T; Han H; Liu X; Liu F; Li Y
Zhonghua Yi Xue Za Zhi; 2014 Nov; 94(43):3432-5. PubMed ID: 25622677
[TBL] [Abstract][Full Text] [Related]
31. Improving the performance of reflex Human Papilloma Virus (HPV) testing in triaging women with atypical squamous cells of undetermined significance (ASCUS): A restrospective study in a tertiary hospital in United Arab Emirates (UAE).
Fakhreldin M; Elmasry K
Vaccine; 2016 Feb; 34(6):823-30. PubMed ID: 26747717
[TBL] [Abstract][Full Text] [Related]
32. Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody.
Peng S; Ferrall L; Gaillard S; Wang C; Chi WY; Huang CH; Roden RBS; Wu TC; Chang YN; Hung CF
mBio; 2021 Jan; 12(1):. PubMed ID: 33468698
[TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus (HPV) E6/E7 mRNA detection in cervical exfoliated cells: a potential triage for HPV-positive women.
Yao YL; Tian QF; Cheng B; Cheng YF; Ye J; Lu WG
J Zhejiang Univ Sci B; 2017 Mar.; 18(3):256-262. PubMed ID: 28271661
[TBL] [Abstract][Full Text] [Related]
34. Prognostic and diagnostic validity of p16/Ki-67, HPV E6/E7 mRNA, and HPV DNA in women with ASCUS: a follow-up study.
Ren C; Zhu Y; Yang L; Zhang X; Liu L; Wang Z; Jiang D
Virol J; 2019 Nov; 16(1):143. PubMed ID: 31752941
[TBL] [Abstract][Full Text] [Related]
35. Do women with high-risk HPV E6/E7 mRNA test positivity and NILM cytology need colposcopy?
Liu Y; Jin X; Gong Y; Ma Y; Du B; Yang L; Wang Y; Zhu W
Infect Agent Cancer; 2023 Sep; 18(1):54. PubMed ID: 37773080
[TBL] [Abstract][Full Text] [Related]
36. Human papillomavirus genotype distribution and E6/E7 oncogene expression in Turkish women with cervical cytological findings.
Tezcan S; Ozgur D; Ulger M; Aslan G; Gurses I; Serin MS; Giray BG; Dilek S; Emekdas G
Asian Pac J Cancer Prev; 2014; 15(9):3997-4003. PubMed ID: 24935586
[TBL] [Abstract][Full Text] [Related]
37. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
[TBL] [Abstract][Full Text] [Related]
38. [Clinical value of p16
Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
[No Abstract] [Full Text] [Related]
39. Detection of cervical intraepithelial neoplasia with HPVE6/E7 mRNA among women with atypical squamous cells of unknown significance.
Li Y; Rong S; Zhi Y; Qiu C; Fan T; Li X
Int J Gynaecol Obstet; 2017 May; 137(2):145-149. PubMed ID: 28170083
[TBL] [Abstract][Full Text] [Related]
40. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]